Carl Walter Fieser, MD
Physical Medicine and Rehabilitation · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 8
Offices
8 locations · Integrated Pain Management Medical Group Inc · 42 clinicians in this group
Looking this up.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Fieser’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A96870 · Current
Licensed to practise in California · since 2006 · expires 2028-06-30 · University of Kansas School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$280,845
Medicare paid this office $280,845 for 170 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 148 | $111,829 | $241 |
| Short return visit (20+ min) | 152 | $88,070 | $83 |
| Return visit (30+ min) | 140 | $36,700 | $102 |
| Telephone medical discussion with physician, 11-20 minutes | 101 | $21,624 | $83 |
| Telephone medical discussion with physician, 21-30 minutes | 52 | $10,706 | $113 |
See all 9 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 148 | $111,829 | $241 |
| Short return visit (20+ min) | 152 | $88,070 | $83 |
| Return visit (30+ min) | 140 | $36,700 | $102 |
| Telephone medical discussion with physician, 11-20 minutes | 101 | $21,624 | $83 |
| Telephone medical discussion with physician, 21-30 minutes | 52 | $10,706 | $113 |
| Therapy procedure using manual technique, each 15 minutes | 11 | $2,597 | $20 |
| Telephone medical discussion with physician, 5-10 minutes | 34 | $2,210 | $53 |
| Acupuncture, each additional 15 minutes | 12 | $1,257 | $24 |
| Acupuncture, initial 15 minutes | 12 | $1,158 | $31 |
Who their Medicare patients are
170 Original Medicare patients in 2024. Average age 69 · Under 65 32% · Women 68% · Also on Medicaid 42% · Health risk score 1.35. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 65% · Diabetes 32% · Depression 31% · Chronic kidney disease 25% · Coronary heart disease 19% · COPD 19% · Heart failure 14% · Cancer 13% · Atrial fibrillation 13%.
The office billed $1,612,078, Medicare allowed $341,994 and paid $280,845; for 2,675 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 170 | 2,675 | 69 | 1.35 | $1,612,078 | $280,845 |
| 2023 | 178 | 3,207 | 68 | 1.35 | $669,809 | $329,707 |
| 2022 | 232 | 4,895 | 68 | 1.32 | $575,534 | $452,412 |
| 2021 | 237 | 6,945 | 66 | 1.53 | $719,884 | $582,756 |
| 2020 | 331 | 7,413 | 67 | 1.59 | $694,936 | $557,663 |
| 2019 | 327 | 4,823 | 66 | 1.57 | $551,966 | $437,975 |
| 2018 | 291 | 3,223 | 65 | 1.52 | $428,965 | $337,900 |
| 2017 | 210 | 2,798 | 64 | 1.55 | $365,967 | $242,912 |
| 2016 | 140 | 3,933 | 62 | 1.47 | $295,960 | $156,452 |
| 2015 | 108 | 2,496 | 63 | 1.51 | $180,905 | $85,847 |
| 2014 | 86 | 433 | 60 | 1.15 | $63,950 | $31,950 |
| 2013 | 44 | 144 | 59 | 1.39 | $19,815 | $10,285 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 163 | $118,564 | $112 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 158 | $108,900 | $241 |
| Short return visit (20+ min) | 163 | $77,380 | $78 |
| Evaluation of psychological test, first hour | 40 | $7,886 | $99 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 68 | $2,780 | $31 |
| Long return visit (40+ min) | 14 | $2,508 | $167 |
2022: 11 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 187 | $120,482 | $244 |
| Short return visit (20+ min) | 197 | $111,128 | $78 |
| Return visit (30+ min) | 194 | $101,602 | $113 |
| Evaluation of psychological test, first hour | 132 | $50,237 | $103 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 157 | $21,851 | $35 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 172 | $15,480 | $56 |
| Extended patient service without direct patient contact, first hour | 70 | $14,335 | $78 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 67 | $3,914 | $58 |
| Acupuncture, initial 15 minutes | 13 | $2,435 | $37 |
| Therapy procedure using manual technique, each 15 minutes | 12 | $2,419 | $21 |
| Acupuncture, each additional 15 minutes | 13 | $1,954 | $27 |
2021: 7 services
| Short return visit (20+ min) | 208 | $134,065 | $85 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 202 | $131,608 | $247 |
| Return visit (30+ min) | 212 | $128,174 | $117 |
| Evaluation of psychological test, first hour | 146 | $70,359 | $103 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 214 | $65,088 | $38 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 158 | $35,987 | $38 |
| Extended patient service without direct patient contact, first hour | 47 | $8,142 | $102 |
2020: 6 services
| Short return visit (20+ min) | 249 | $159,209 | $68 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 234 | $132,678 | $244 |
| Evaluation of psychological test, first hour | 256 | $100,510 | $108 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 309 | $70,486 | $39 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 233 | $43,745 | $39 |
| Return visit (30+ min) | 219 | $42,881 | $88 |
2019: 9 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 276 | $158,488 | $240 |
| Return visit (30+ min) | 294 | $143,015 | $94 |
| Short return visit (20+ min) | 219 | $62,640 | $66 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 240 | $41,978 | $38 |
| New patient visit (60+ min) | 79 | $13,637 | $173 |
| Evaluation of psychological test, first hour | 27 | $3,243 | $105 |
| Long return visit (40+ min) | 14 | $2,394 | $133 |
| Administration of psychological or neuropsychological test by technician, each additional 30 minutes | 80 | $2,076 | $25 |
| New patient visit (45+ min) | 12 | $1,839 | $153 |
2018: 9 services
| Return visit (30+ min) | 249 | $156,211 | $93 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 242 | $127,871 | $239 |
| New patient visit (60+ min) | 53 | $9,874 | $186 |
| Long return visit (40+ min) | 42 | $8,260 | $129 |
| Short return visit (20+ min) | 81 | $7,813 | $51 |
| New patient visit (45+ min) | 53 | $7,083 | $134 |
| Psychological testing with interpretation and report by technician per hour | 51 | $6,304 | $58 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 49 | $3,919 | $16 |
| Psychological testing with interpretation and report by computer | 55 | $1,996 | $24 |
2017: 14 services
| Return visit (30+ min) | 171 | $104,357 | $107 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 161 | $82,631 | $248 |
| Short return visit (20+ min) | 86 | $15,459 | $67 |
| New patient visit (45+ min) | 53 | $8,607 | $162 |
| Chemical analysis using chromatography technique | 51 | $7,865 | $24 |
| Psychological testing with interpretation and report by psychologist or physician per hour | 59 | $7,537 | $75 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 34 | $2,643 | $19 |
| PCP drug level | 51 | $2,135 | $20 |
| Psychological testing with interpretation and report by technician per hour | 20 | $1,432 | $68 |
| Clozapine level | 51 | $1,342 | $25 |
| Creatinine level to test for kidney function or muscle injury | 51 | $1,127 | $7 |
| Haloperidol level | 51 | $1,057 | $20 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $573 | $34 |
| Body fluid ph level | 51 | $519 | $5 |
2016: 11 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 97 | $41,342 | $211 |
| Return visit (30+ min) | 86 | $32,009 | $90 |
| Chemical analysis using chromatography technique | 100 | $29,509 | $24 |
| Short return visit (20+ min) | 98 | $28,561 | $59 |
| Clozapine level | 100 | $5,061 | $25 |
| New patient visit (45+ min) | 32 | $4,498 | $141 |
| Creatinine level to test for kidney function or muscle injury | 100 | $4,229 | $7 |
| Haloperidol level | 100 | $3,985 | $19 |
| Body fluid ph level | 100 | $1,950 | $5 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 18 | $706 | $35 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 19 | $605 | $15 |
2015: 17 services
| Short return visit (20+ min) | 77 | $16,652 | $61 |
| Return visit (30+ min) | 55 | $15,270 | $87 |
| Chemical analysis using chromatography technique | 54 | $9,394 | $24 |
| Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter | 64 | $8,146 | $97 |
| Opiate(s), drug and metabolites, each procedure | 55 | $6,877 | $26 |
| New patient visit (45+ min) | 25 | $3,587 | $143 |
| Chemical analysis | 54 | $3,132 | $24 |
| Meprobamate | 55 | $2,938 | $24 |
| Methadone | 56 | $2,809 | $22 |
| Amphetamine or methamphetamine | 56 | $2,674 | $21 |
| Dihydromorphinone | 55 | $2,228 | $34 |
| Nortriptyline | 55 | $2,223 | $18 |
| PCP drug level | 54 | $2,136 | $20 |
| Dihydrocodeinone | 55 | $1,790 | $28 |
| Creatinine level to test for kidney function or muscle injury | 55 | $1,076 | $7 |
| Alcohol (ethanol); any specimen except breath | 54 | $937 | $14 |
| Body fluid ph level | 55 | $530 | $5 |
2014: 4 services
| Return visit (30+ min) | 43 | $13,727 | $95 |
| Short return visit (20+ min) | 48 | $10,408 | $61 |
| New patient visit (45+ min) | 33 | $4,651 | $141 |
| Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | 29 | $642 | $19 |
2013: 4 services
| Short return visit (20+ min) | 29 | $3,786 | $65 |
| New patient visit (45+ min) | 21 | $2,838 | $135 |
| Return visit (30+ min) | 12 | $2,099 | $95 |
| Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | 26 | $686 | $20 |
Medicaid work
$12,089 in 2024
Medicaid paid $12,089 for 178 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 165 | $11,639 |
| Return visit (30+ min) | 13 | $450 |
| 2024 | 178 | 2 | 19 | $12,089 |
| 2023 | 640 | 5 | 48 | $37,736 |
| 2022 | 1,665 | 8 | 57 | $71,273 |
| 2021 | 1,694 | 5 | 91 | $70,530 |
| 2020 | 1,646 | 5 | 83 | $43,215 |
| 2019 | 805 | 3 | 62 | $19,915 |
| 2018 | 205 | 1 | 28 | $10,904 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 292 | $20,143 |
| Short return visit (20+ min) | 241 | $15,324 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 12 | $1,722 |
| Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method; first 30 minutes | 15 | $548 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 80 | $0 |
2022
| Return visit (30+ min) | 423 | $27,747 |
| Short return visit (20+ min) | 633 | $26,372 |
| Psychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed; first hour | 102 | $5,918 |
| Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method; first 30 minutes | 229 | $4,602 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 89 | $3,403 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 13 | $2,238 |
| Principal care management services, for a single high-risk disease, with the following required elements: one complex chronic condition expected to last at least 3 months, and that places the patient at significant risk of hospitalization, acute exacerbation/decompensation, functional decline, or death, the condition requires development, monitoring, or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen and/or the management of the condition is unusually complex due to comorbidities, ongoing communication and care coordination between relevant practitioners furnishing care; first 30 minutes of clinical staff time directed by physician or other qualified health care professional, per calendar month. | 30 | $993 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 146 | $0 |
2021
| Return visit (30+ min) | 288 | $28,271 |
| Short return visit (20+ min) | 327 | $19,566 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 787 | $11,859 |
| Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method; first 30 minutes | 212 | $5,563 |
| Psychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed; first hour | 80 | $5,270 |
2020
| Short return visit (20+ min) | 661 | $17,611 |
| Psychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed; first hour | 125 | $8,326 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 596 | $7,860 |
| Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method; first 30 minutes | 149 | $4,916 |
| Return visit (30+ min) | 115 | $4,502 |
2019
| Return visit (30+ min) | 356 | $10,234 |
| Short return visit (20+ min) | 209 | $7,504 |
| Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method; first 30 minutes | 240 | $2,177 |
2018
| Return visit (30+ min) | 205 | $10,904 |
Drugs they prescribed that Part D paid
$26,846
Pharmacies billed $26,846 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 50% of their Part D prescriptions (373 of 746) in 2024. Above the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%. Long-acting opioids: 11% of their opioid prescriptions.
726 generic and 20 brand-name prescriptions · $26,846 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 221 | $6,618 | $30 |
| Buprenorphine | 16 | $4,023 | $251 |
| Naloxone | 30 | $1,673 | $56 |
| Gabapentin | 107 | $1,165 | $11 |
| Oxycodone | 58 | $1,134 | $20 |
See all 18 drugs
| Hydrocodone-Acetaminophen | 221 | $6,618 | $30 |
| Buprenorphine | 16 | $4,023 | $251 |
| Naloxone | 30 | $1,673 | $56 |
| Gabapentin | 107 | $1,165 | $11 |
| Oxycodone | 58 | $1,134 | $20 |
| Oxycodone-Acetaminophen | 19 | $896 | $47 |
| Trazodone | 11 | $813 | $74 |
| Pregabalin | 16 | $496 | $31 |
| Morphine Sulfate Er | 16 | $450 | $28 |
| Diclofenac | 19 | $422 | $22 |
| Duloxetine | 17 | $219 | $13 |
| Zolpidem | 21 | $137 | $7 |
| Cyclobenzaprine | 16 | $124 | $8 |
| Tizanidine | 28 | $112 | $4 |
| Ibuprofen | 16 | $93 | $6 |
| Baclofen | 11 | $71 | $6 |
| Naproxen | 13 | $67 | $5 |
| Tramadol | 13 | $46 | $4 |
Year by year
| 2024 | 746 | 165 | 50% (373) | 3% | $26,846 |
| 2023 | 663 | 169 | 55% (364) | 4% | $34,391 |
| 2022 | 249 | 110 | 53% (133) | 6% | $14,660 |
| 2021 | 1,209 | 247 | 54% (648) | 11% | $68,273 |
| 2020 | 1,696 | 290 | 55% (935) | 8% | $84,079 |
| 2019 | 3,818 | 354 | 57% (2,188) | 11% | $247,101 |
| 2018 | 3,328 | 319 | 57% (1,894) | 10% | $226,984 |
| 2017 | 2,848 | 230 | 56% (1,592) | 13% | $244,033 |
| 2016 | 2,746 | 198 | 57% (1,556) | 14% | $287,337 |
| 2015 | 1,580 | 147 | 59% (935) | 12% | $169,755 |
| 2014 | 912 | 91 | 60% (548) | 17% | $104,082 |
| 2013 | 281 | 50 | 50% (140) | 32% | $54,789 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Hydrocodone-Acetaminophen | 166 | $6,067 | $37 |
| Oxycontin | 11 | $5,211 | $474 |
| Buprenorphine | 14 | $3,557 | $254 |
| Oxycodone | 74 | $1,595 | $22 |
| Oxycodone-Acetaminophen | 37 | $1,589 | $43 |
| Pregabalin | 24 | $1,463 | $61 |
| Lidocaine | 12 | $1,434 | $120 |
| Gabapentin | 79 | $1,300 | $16 |
| Naloxone | 11 | $932 | $85 |
| Diclofenac | 22 | $902 | $41 |
| Morphine Sulfate Er | 18 | $535 | $30 |
| Duloxetine | 13 | $343 | $26 |
| Cyclobenzaprine | 24 | $278 | $12 |
| Zolpidem | 16 | $136 | $9 |
| Baclofen | 11 | $136 | $12 |
| Amitriptyline | 11 | $129 | $12 |
| Naproxen | 11 | $114 | $10 |
| Ibuprofen | 11 | $112 | $10 |
| Tramadol | 15 | $50 | $3 |
2022: 5 drugs
| Hydrocodone-Acetaminophen | 54 | $1,829 | $34 |
| Gabapentin | 26 | $845 | $33 |
| Oxycodone | 23 | $551 | $24 |
| Morphine Sulfate Er | 12 | $448 | $37 |
| Oxycodone-Acetaminophen | 13 | $341 | $26 |
2021: 21 drugs
| Hydrocodone-Acetaminophen | 361 | $12,644 | $35 |
| Narcan | 81 | $10,619 | $131 |
| Oxycontin | 26 | $9,107 | $350 |
| Gabapentin | 130 | $2,261 | $17 |
| Pregabalin | 37 | $2,080 | $56 |
| Oxycodone | 80 | $1,842 | $23 |
| Oxycodone-Acetaminophen | 57 | $1,790 | $31 |
| Morphine Sulfate Er | 42 | $1,477 | $35 |
| Diclofenac | 17 | $1,340 | $79 |
| Tramadol Hcl Er | 11 | $1,077 | $98 |
| Baclofen | 36 | $590 | $16 |
| Cyclobenzaprine | 43 | $531 | $12 |
| Acetaminophen-Codeine | 14 | $333 | $24 |
| Trazodone | 22 | $312 | $14 |
| Duloxetine | 23 | $291 | $13 |
| Amitriptyline | 12 | $268 | $22 |
| Hydromorphone | 11 | $254 | $23 |
| Zolpidem | 25 | $245 | $10 |
| Tizanidine | 17 | $136 | $8 |
| Naproxen | 20 | $98 | $5 |
| Ibuprofen | 14 | $66 | $5 |
2020: 24 drugs
| Hydrocodone-Acetaminophen | 484 | $13,606 | $28 |
| Oxycontin | 35 | $12,989 | $371 |
| Movantik | 11 | $4,658 | $423 |
| Narcan | 35 | $4,555 | $130 |
| Oxycodone-Acetaminophen | 68 | $3,842 | $56 |
| Pregabalin | 62 | $3,817 | $62 |
| Buprenorphine | 14 | $3,732 | $267 |
| Oxycodone | 146 | $3,642 | $25 |
| Gabapentin | 175 | $2,636 | $15 |
| Diclofenac | 39 | $2,318 | $59 |
| Morphine Sulfate Er | 61 | $1,626 | $27 |
| Cyclobenzaprine | 75 | $759 | $10 |
| Duloxetine | 37 | $692 | $19 |
| Tizanidine | 37 | $667 | $18 |
| Acetaminophen-Codeine | 24 | $640 | $27 |
| Baclofen | 42 | $529 | $13 |
| Hydromorphone | 34 | $516 | $15 |
| Trazodone | 36 | $343 | $10 |
| Amitriptyline | 13 | $291 | $22 |
| Ibuprofen | 32 | $282 | $9 |
| Methadone | 19 | $251 | $13 |
| Zolpidem | 41 | $226 | $6 |
| Naproxen | 26 | $168 | $6 |
| Omeprazole | 20 | $138 | $7 |
2019: 37 drugs
| Lyrica | 80 | $43,696 | $546 |
| Oxycontin | 99 | $42,213 | $426 |
| Hydrocodone-Acetaminophen | 1,075 | $31,340 | $29 |
| Narcan | 115 | $14,951 | $130 |
| Butrans | 15 | $11,245 | $750 |
| Norco | 17 | $9,337 | $549 |
| Oxycodone | 333 | $9,328 | $28 |
| Oxycodone-Acetaminophen | 170 | $8,983 | $53 |
| Lidoderm | 14 | $7,359 | $526 |
| Buprenorphine | 12 | $6,326 | $527 |
| Gabapentin | 423 | $5,792 | $14 |
| Morphine Sulfate Er | 149 | $4,770 | $32 |
| Movantik | 12 | $4,325 | $360 |
| Nucynta | 12 | $4,010 | $334 |
| Pregabalin | 35 | $2,818 | $81 |
| Diclofenac | 53 | $2,794 | $53 |
| Fentanyl | 26 | $2,595 | $100 |
| Duloxetine | 78 | $1,826 | $23 |
| Cyclobenzaprine | 160 | $1,674 | $10 |
| Lidocaine | 15 | $1,619 | $108 |
| Methadone | 75 | $1,284 | $17 |
| Acetaminophen-Codeine | 52 | $1,112 | $21 |
| Baclofen | 80 | $1,111 | $14 |
| Trazodone | 80 | $1,071 | $13 |
| Hydromorphone | 62 | $1,036 | $17 |
| Tizanidine | 62 | $966 | $16 |
| Zolpidem | 96 | $850 | $9 |
| Amitriptyline | 25 | $528 | $21 |
| Ibuprofen | 57 | $495 | $9 |
| Celecoxib | 22 | $398 | $18 |
| Naproxen | 48 | $373 | $8 |
| Morphine Sulfate | 14 | $357 | $25 |
| Tramadol | 42 | $210 | $5 |
| Nortriptyline | 19 | $130 | $7 |
| Omeprazole | 16 | $102 | $6 |
| Methocarbamol | 14 | $99 | $7 |
| Meloxicam | 11 | $43 | $4 |
2018: 37 drugs
| Lyrica | 130 | $72,113 | $555 |
| Hydrocodone-Acetaminophen | 933 | $27,820 | $30 |
| Oxycontin | 58 | $27,232 | $470 |
| Norco | 20 | $11,041 | $552 |
| Oxycodone | 309 | $10,095 | $33 |
| Fentanyl | 77 | $6,871 | $89 |
| Oxycodone-Acetaminophen | 123 | $6,654 | $54 |
| Morphine Sulfate Er | 148 | $6,176 | $42 |
| Lidoderm | 12 | $5,518 | $460 |
| Nucynta | 16 | $5,424 | $339 |
| Gabapentin | 378 | $5,379 | $14 |
| Narcan | 28 | $3,621 | $129 |
| Voltaren | 13 | $2,418 | $186 |
| Diclofenac | 34 | $1,729 | $51 |
| Trazodone | 76 | $1,507 | $20 |
| Endocet | 18 | $1,252 | $70 |
| Baclofen | 64 | $1,242 | $19 |
| Duloxetine | 58 | $1,227 | $21 |
| Lidocaine | 12 | $1,202 | $100 |
| Tizanidine | 67 | $1,190 | $18 |
| Methadone | 57 | $988 | $17 |
| Cyclobenzaprine | 117 | $907 | $8 |
| Celecoxib | 15 | $649 | $43 |
| Zolpidem | 89 | $618 | $7 |
| Ibuprofen | 76 | $579 | $8 |
| Hydromorphone | 31 | $563 | $18 |
| Amitriptyline | 14 | $505 | $36 |
| Acetaminophen-Codeine | 19 | $501 | $26 |
| Carisoprodol | 34 | $463 | $14 |
| Escitalopram | 18 | $419 | $23 |
| Morphine Sulfate | 20 | $348 | $17 |
| Tramadol | 42 | $310 | $7 |
| Naproxen | 37 | $276 | $7 |
| Sumatriptan | 16 | $230 | $14 |
| Nortriptyline | 16 | $105 | $7 |
| Promethazine | 18 | $97 | $5 |
| Omeprazole | 12 | $80 | $7 |
2017: 35 drugs
| Lyrica | 125 | $63,792 | $510 |
| Oxycontin | 117 | $54,154 | $463 |
| Hydrocodone-Acetaminophen | 715 | $18,479 | $26 |
| Norco | 18 | $11,026 | $613 |
| Oxycodone-Acetaminophen | 145 | $7,659 | $53 |
| Oxycodone | 212 | $7,608 | $36 |
| Morphine Sulfate Er | 109 | $6,203 | $57 |
| Gabapentin | 302 | $5,185 | $17 |
| Fentanyl | 51 | $4,832 | $95 |
| Lidoderm | 11 | $4,222 | $384 |
| Lidocaine | 19 | $2,692 | $142 |
| Diclofenac | 27 | $1,287 | $48 |
| Methadone | 67 | $1,204 | $18 |
| Tizanidine | 58 | $1,185 | $20 |
| Tramadol Hcl Er | 11 | $984 | $89 |
| Baclofen | 41 | $802 | $20 |
| Trazodone | 65 | $788 | $12 |
| Cyclobenzaprine | 94 | $768 | $8 |
| Desvenlafaxine Succinate Er | 11 | $752 | $68 |
| Duloxetine | 35 | $729 | $21 |
| Amitriptyline | 22 | $693 | $32 |
| Zolpidem | 82 | $628 | $8 |
| Celecoxib | 15 | $567 | $38 |
| Hydromorphone | 34 | $524 | $15 |
| Ibuprofen | 54 | $449 | $8 |
| Naproxen | 47 | $300 | $6 |
| Acetaminophen-Codeine | 11 | $254 | $23 |
| Escitalopram | 29 | $226 | $8 |
| Carisoprodol | 45 | $221 | $5 |
| Tramadol | 29 | $160 | $6 |
| Morphine Sulfate | 16 | $139 | $9 |
| Ibu | 19 | $113 | $6 |
| Topiramate | 14 | $104 | $7 |
| Venlafaxine Hcl Er | 12 | $98 | $8 |
| Omeprazole | 20 | $58 | $3 |
2016: 35 drugs
| Lyrica | 129 | $54,714 | $424 |
| Oxycontin | 73 | $45,567 | $624 |
| Evzio | 12 | $45,373 | $3,781 |
| Hydrocodone-Acetaminophen | 660 | $23,105 | $35 |
| Fentanyl | 119 | $16,369 | $138 |
| Oxycodone Hcl Er | 11 | $9,712 | $883 |
| Morphine Sulfate Er | 119 | $9,276 | $78 |
| Oxycodone-Acetaminophen | 138 | $8,845 | $64 |
| Oxycodone | 182 | $8,274 | $45 |
| Gabapentin | 292 | $5,709 | $20 |
| Lidocaine | 16 | $5,241 | $328 |
| Pristiq | 15 | $4,412 | $294 |
| Nucynta Er | 11 | $3,854 | $350 |
| Amitiza | 11 | $3,465 | $315 |
| Nucynta | 12 | $3,149 | $262 |
| Tizanidine | 59 | $2,203 | $37 |
| Methadone | 78 | $1,948 | $25 |
| Amitriptyline | 30 | $1,048 | $35 |
| Zolpidem | 87 | $972 | $11 |
| Morphine Sulfate | 38 | $958 | $25 |
| Tramadol Hcl Er | 12 | $773 | $64 |
| Ibuprofen | 88 | $712 | $8 |
| Baclofen | 25 | $619 | $25 |
| Hydromorphone | 40 | $609 | $15 |
| Carisoprodol | 73 | $538 | $7 |
| Duloxetine | 21 | $527 | $25 |
| Trazodone | 72 | $455 | $6 |
| Cyclobenzaprine | 60 | $396 | $7 |
| Escitalopram | 28 | $307 | $11 |
| Naproxen | 26 | $192 | $7 |
| Venlafaxine Hcl Er | 14 | $189 | $13 |
| Tramadol | 28 | $188 | $7 |
| Terazosin | 11 | $137 | $12 |
| Omeprazole | 13 | $89 | $7 |
| Diazepam | 11 | $41 | $4 |
2015: 22 drugs
| Oxycontin | 42 | $62,912 | $1,498 |
| Lyrica | 91 | $34,920 | $384 |
| Hydrocodone-Acetaminophen | 427 | $12,192 | $29 |
| Fentanyl | 71 | $9,586 | $135 |
| Morphine Sulfate Er | 107 | $8,988 | $84 |
| Oxycodone-Acetaminophen | 99 | $7,186 | $73 |
| Oxycodone | 97 | $3,923 | $40 |
| Gabapentin | 146 | $2,854 | $20 |
| Amitriptyline | 41 | $1,558 | $38 |
| Tizanidine | 17 | $1,107 | $65 |
| Carisoprodol | 74 | $1,005 | $14 |
| Cyclobenzaprine | 38 | $704 | $19 |
| Methadone | 19 | $542 | $29 |
| Morphine Sulfate | 17 | $285 | $17 |
| Ibuprofen | 38 | $283 | $7 |
| Zolpidem | 47 | $282 | $6 |
| Hydromorphone | 19 | $260 | $14 |
| Terazosin | 14 | $188 | $13 |
| Diclofenac | 12 | $182 | $15 |
| Trazodone | 32 | $146 | $5 |
| Escitalopram | 14 | $99 | $7 |
| Tramadol | 18 | $66 | $4 |
2014: 17 drugs
| Oxycontin | 37 | $52,180 | $1,410 |
| Lyrica | 57 | $20,587 | $361 |
| Morphine Sulfate Er | 88 | $6,067 | $69 |
| Fentanyl | 51 | $5,778 | $113 |
| Hydrocodone-Acetaminophen | 217 | $4,564 | $21 |
| Oxycodone-Acetaminophen | 47 | $3,111 | $66 |
| Gabapentin | 86 | $1,924 | $22 |
| Oxycodone | 48 | $1,456 | $30 |
| Carisoprodol | 40 | $892 | $22 |
| Amitriptyline | 24 | $669 | $28 |
| Methadone | 21 | $428 | $20 |
| Zolpidem | 45 | $372 | $8 |
| Morphine Sulfate | 17 | $159 | $9 |
| Tramadol | 17 | $121 | $7 |
| Ibuprofen | 19 | $118 | $6 |
| Naproxen | 14 | $116 | $8 |
| Temazepam | 11 | $75 | $7 |
2013: 8 drugs
| Oxycontin | 22 | $34,434 | $1,565 |
| Lyrica | 31 | $7,031 | $227 |
| Cymbalta | 11 | $2,405 | $219 |
| Fentanyl | 13 | $1,514 | $116 |
| Morphine Sulfate Er | 21 | $1,324 | $63 |
| Hydrocodone-Acetaminophen | 55 | $1,099 | $20 |
| Gabapentin | 15 | $515 | $34 |
| Naproxen | 13 | $89 | $7 |
Money from drug and device companies
$300 in 2025
| 2025 | 3 | 13 | None | $300 |
| 2024 | 7 | 17 | None | $367 |
| 2023 | 7 | 13 | None | $223 |
| 2022 | 4 | 7 | None | $89 |
| 2021 | 2 | 8 | None | $51 |
| 2020 | 5 | 8 | None | $132 |
| 2019 | 14 | 115 | None | $1,057 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Electronic Waveform Lab | None | $234 | 10 payments
|
| Forte Bio-Pharma | Prolate | $47 | 2 payments
|
| Scilex Pharmaceuticals | Ztlido | $18 | 1 payment
|
See all 13 published payments
| Electronic Waveform Lab | Meals · 2025-11-13 | None | $21 |
| Electronic Waveform Lab | Meals · 2025-10-31 | None | $22 |
| Electronic Waveform Lab | Meals · 2025-09-26 | None | $23 |
| Electronic Waveform Lab | Meals · 2025-07-25 | None | $22 |
| Electronic Waveform Lab | Meals · 2025-06-20 | None | $24 |
| Forte Bio-Pharma | Meals · 2025-05-05 | Prolate | $25 |
| Electronic Waveform Lab | Meals · 2025-05-02 | None | $25 |
| Electronic Waveform Lab | Meals · 2025-04-17 | None | $34 |
| Forte Bio-Pharma | Meals · 2025-04-03 | Prolate | $22 |
| Electronic Waveform Lab | Meals · 2025-03-14 | None | $19 |
| Electronic Waveform Lab | Meals · 2025-02-20 | None | $23 |
| Electronic Waveform Lab | Meals · 2025-01-31 | None | $23 |
| Scilex Pharmaceuticals | Meals · 2025-01-07 | Ztlido | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $367
| Electronic Waveform Lab | None | $172 | 7 payments
|
| Forte Bio-Pharma | Nalocet | $73 | 3 payments
|
| Scilex Pharmaceuticals | Ztlido | $48 | 3 payments
|
| Medtronic | Intellis Adaptivestim | $20 | 1 payment
|
| Abbvie | Qulipta | $20 | 1 payment
|
| Nalu Medical | Nalu Neurostimulation System | $18 | 1 payment
|
| Abbott Laboratories | Eterna | $16 | 1 payment
|
2023: $223
| Collegium Pharmaceutical | Belbuca | $67 | 4 payments
|
| Scilex Pharmaceuticals | Ztlido | $60 | 4 payments
|
| Electronic Waveform Lab | None | $22 | 1 payment
|
| Abbvie | Qulipta | $20 | 1 payment
|
| Pfizer | Nurtec Odt | $20 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $19 | 1 payment
|
| RedHill Biopharma | Talicia | $15 | 1 payment
|
2022: $89
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $38 | 2 payments
|
| Forte Bio-Pharma | Prolate | $20 | 1 payment
|
| RedHill Biopharma | Movantik | $18 | 1 payment
|
| Collegium Pharmaceutical | Belbuca | $13 | 1 payment
|
2021: $51
| Forte Bio-Pharma | Nalocet | $36 | 1 payment
|
| Collegium Pharmaceutical | Xtampza | $15 | 1 payment
|
2020: $132
| Collegium Pharmaceutical | Xtampza | $65 | 4 payments
|
| Teva Pharmaceuticals USA | Ajovy | $23 | 1 payment
|
| Scilex Pharmaceuticals | Ztlido | $21 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Amitiza | $15 | 1 payment
|
| Electronic Waveform Lab | None | $8 | 1 payment
|
2019: $1,057
| BioDelivery Sciences International | Bunavail 2.1 Mg 30-Count Box | $267 | 11 payments
|
| Pfizer | Lyrica | $262 | 43 payments
|
| Collegium Pharmaceutical | Xtampza | $131 | 25 payments
|
| Takeda Pharmaceuticals U.S.A. | Amitiza | $122 | 18 payments
|
| Scilex Pharmaceuticals | Ztlido 30 Pouch in 1 Carton 1 Patch in 1 Pouch | $71 | 4 payments
|
| Electronic Waveform Lab | None | $39 | 4 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Lucemyra | $36 | 2 payments
|
| Arbor Pharmaceuticals | Horizant | $28 | 2 payments
|
| Teva Pharmaceuticals USA | Ajovy | $21 | 1 payment
|
| Gilead Sciences | None | $20 | 1 payment
|
| US WorldMeds | Lucemyra/Lofexidine | $18 | 1 payment
|
| Si-Bone | Ifuse Implant | $15 | 1 payment
|
| Novartis Pharmaceuticals | Aimovig | $14 | 1 payment
|
| Medline Industries | None | $12 | 1 payment
|
Professional record
- NPI
- 1346515319
- Licence
- CA A96870California A96870: Current · expires 2028-06-30
- Trained
- University of Kansas School of Med (Kc/Wich/Sal), 2002
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2081P2900X (2081P2900X); Federal specialty code 208100000X (208100000X)
- Mailing address
- 450 N Wiget Ln, Walnut Creek, CA, 94598
- NPI first listed
- 2012-03-09
- NPI last updated
- 2012-09-13
This is when the NPI record was last certified, not a medical board exam.